RBC Capital Maintains Outperform on Thermo Fisher Scientific, Raises Price Target to $698
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Conor McNamara maintains an 'Outperform' rating on Thermo Fisher Scientific (NYSE:TMO) and raises the price target from $662 to $698.
July 27, 2023 | 4:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital maintains an 'Outperform' rating on Thermo Fisher Scientific and raises the price target to $698, which may positively impact the stock in the short term.
The raised price target by RBC Capital indicates a positive outlook for Thermo Fisher Scientific. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100